Benjamin Hsu

T‐lymphocyte entry into the central nervous system

William F. Hickey, Benjamin Hsu, Hironobu Kimura · Journal of Neuroscience Research · 1991 · 1.2K citations

Life Sciences, Immunology, Neuroscience +15

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

Robert D. Inman, John C. Davis, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2008 · 593 citations

Medicine, Clinical Sciences, Pharmacotherapy +7

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

Minhong Yan, John Ridgway Brady, Betty S. Chan et al. · Current Biology · 2001 · 390 citations · Full text

Life Sciences, Genetics, Immunology +13

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsokos et al. · The Lancet · 2018 · 324 citations

Life Sciences, Immunology, Pharmacology +14

Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators

Benjamin Hsu, Susan M. Harless, R. Coleman Lindsley et al. · The Journal of Immunology · 2002 · 308 citations · Full text

Life Sciences, Cell Biology, Immunology +17